Ignite Creation Date:
2024-05-06 @ 2:24 AM
Last Modification Date:
2024-10-26 @ 11:17 AM
Study NCT ID:
NCT02034110
Status:
COMPLETED
Last Update Posted:
2023-08-21
First Post:
2013-12-05
Brief Title:
Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03-12
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-10
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-05
First Submit QC Date:
January 9 2014
Study First Post Date:
2014-01-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-08-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2022-06-08
Disp First Submit QC Date:
June 8 2022
Disp First Post Date:
2022-06-10
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-07-24
Last Update Post Date:
2023-08-21
Last Update Post Date Type:
ACTUAL